Recruiting
Phase 1
Phase 2

Topical Infliximab in Eyes With Penetrating Keratoplasty

Sponsor:

Centre hospitalier de l'Université de Montréal (CHUM)

Code:

NCT05180994

Conditions

Glaucoma Following Surgery

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Topical infliximab

No topical infliximab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-29. This information was provided to ClinicalTrials.gov by Centre hospitalier de l'Université de Montréal (CHUM) on 2024-08-22.